Descripción de la empresa
Aveanna Healthcare Holdings Inc. operates as a diversified home care platform company that delivers pediatric and adult healthcare services throughout the United States, utilizing a patient-centered delivery model designed to help patients remain in their homes while minimizing the overutilization of high-cost care settings. The enterprise functions within the broader Healthcare sector, specifically classified under the Medical Care Facilities industry, which positions it to capture demand for in-home medical support and long-term care solutions. This organization employs approximately 3,500 individuals and holds a total market capitalization of $1.40B, generating trailing twelve-month revenue of $2.43B. The combination of a $1.40B market cap and $2.43B in annual revenue suggests a significant operational scale within the specialized home care market, indicating a substantial asset base and a mature business model capable of supporting a large workforce and extensive service network across multiple regions.
Salud financiera
The company reported total revenue of $2.43B over the trailing twelve months, with net income reaching $225.03M and EBITDA standing at $289.08M, illustrating a cost structure where operating expenses and taxes absorb roughly 9.2% of total sales to arrive at the final profit. The firm generated free cash flow of $79.12M, which provides a measure of financial flexibility allowing for potential capital expenditures or debt servicing without immediate reliance on external financing. Margin analysis reveals a gross margin of 33.1%, an operating margin of 11.4%, and a profit margin of 9.2%, where the spread between gross and profit margins highlights the significant fixed costs associated with staffing and facility operations inherent to the medical care industry. On the balance sheet, the company holds $197.16M in cash against total debt of $1.51B, resulting in a debt-to-equity ratio of 775.91, which indicates a highly leveraged capital structure rather than a conservative one. Liquidity is assessed via a current ratio of 1.32, signaling that current assets exceed current liabilities by a moderate margin, suggesting the ability to meet short-term obligations though not with an excessive buffer. Return metrics show a Return on Equity of 615.7% and a Return on Assets of 9.5%, figures that reflect the intense leverage on the equity base and the efficiency of asset utilization in generating returns relative to the total asset pool.
Evaluación de valoración
Valuation multiples indicate a trailing P/E ratio of 6.14 and a forward P/E of 9.23, where the difference between these two figures implies market expectations for significant earnings growth in the coming period as the forward multiple is notably higher than the trailing one. The price-to-book ratio stands at 6.97, suggesting that the market values the company at a substantial premium relative to its net asset book value, often driven by growth prospects or intangible assets not fully captured on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 0.58 and an EV/EBITDA of 9.41, which provide context on the company's pricing power and operational efficiency when adjusted for enterprise value and earnings before interest and taxes. Price momentum is observed within a 52-week trading range between a low of $3.73 and a high of $10.32, providing the necessary context to evaluate current entry points relative to the established volatility band. The stock exhibits a beta of 2.09, indicating that price movements are expected to be highly volatile and will likely fluctuate at more than twice the magnitude of the broader market index.
Growth & Income
Revenue growth for the trailing twelve months stands at 27.4%, while earnings growth is reported at 465.2%, demonstrating that profitability is expanding at a rate vastly superior to top-line revenue expansion. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm retains all generated earnings to reinvest into operations, expansion, or debt reduction rather than distributing cash to shareholders. The disparity between the massive earnings growth figure and the steady revenue growth implies that the company is achieving significant leverage through cost efficiencies, scale, or margin expansion rather than merely selling more services. Overall, the growth and income profile is characterized by aggressive earnings acceleration without shareholder payouts, relying entirely on retained earnings to fuel internal capital allocation strategies and future operational capabilities.
Comparación con pares
Aveanna Healthcare Holdings Inc. (AVAH) opera en la industria de Instalaciones de Atención Médica. Así se compara con sus pares más cercanos por capitalización de mercado:
El ratio P/E promedio de la industria Instalaciones de Atención Médica es 28.6x. Aveanna Healthcare Holdings Inc. cotiza a un P/E de 6.0.